# First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.

> **NCT06240546** · PHASE1 · RECRUITING · sponsor: **Luye Pharma Group Ltd.** · enrollment: 102 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** LPM6690176

## Key facts

- **NCT ID:** NCT06240546
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-12
- **Primary completion:** 2026-02
- **Final completion:** 2027-02
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06240546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06240546, "First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT06240546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*